广康生化：股东计划减持公司股份不超过133万股
Yingde Greatchem Chemicals Yingde Greatchem Chemicals (SZ:300804) Mei Ri Jing Ji Xin Wen·2025-09-14 08:16

Group 1 - The core point of the news is that shareholders of Guangkang Biochemical plan to reduce their holdings by up to 1.7973% of the total share capital within three months through centralized bidding and block trading [1] - Guangkang Biochemical's major revenue source is pesticides, which account for 99.84% of its total revenue, while other businesses contribute only 0.16% [2] - As of the latest report, Guangkang Biochemical has a market capitalization of 3 billion yuan [2]